Anavex Life Sciences
AVXL
#7563
Rank
C$0.54 B
Marketcap
C$6.08
Share price
-1.12%
Change (1 day)
-42.96%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -C$72.71 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$71.23 Million a decrease over its 2023 earnings that were of -C$62.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$72.71 Million2.09%
2024 -C$71.23 Million14.77%
2023 -C$62.06 Million-17.49%
2022 -C$75.22 Million22.96%
2021 -C$61.17 Million35.36%
2020 -C$45.19 Million12.65%
2019 -C$40.12 Million29.09%
2018 -C$31.08 Million36.33%
2017 -C$22.8 Million17.11%
2016 -C$19.47 Million20.91%
2015 -C$16.1 Million-6.29%
2014 -C$17.18 Million337.28%
2013 -C$3.93 Million
2008 -C$7.27 Million106.01%
2007 -C$3.53 Million8848.98%
2006 -C$0.04 Million-79.99%
2005 -C$0.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
C$92.27 M-228.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-C$9.15 Million-87.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
C$90.58 M-225.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-C$23.89 Million-66.78%๐Ÿ‡บ๐Ÿ‡ธ USA